Show simple item record

dc.creatorBonilla, Guillermo A. 
dc.creatorGutierrez, Camilo 
dc.creatorBautista, Maria P. 
dc.creatorLlinas, Adolfo M. 
dc.creatorMonsalvo, Daniel J. 
dc.date.accessioned2020-08-06T16:21:27Z
dc.date.available2020-08-06T16:21:27Z
dc.date.created2016
dc.identifier.issnISSN: 0883-5403
dc.identifier.issnEISSN: 1532-8406
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/26364
dc.description.abstractWe had the opportunity to read last issue’s article by Sharfman et al [1] regarding the use of an intermittent pneumatic compression device (IPCD) and tranexamic acid (TXA) as prophylactic measures against venous thromboembolic disease and bleeding, respectively. The authors’ research on the subject is a valuable contribution to the study of relevant perioperative complications after hip or knee arthroplasty, and their stepwise approach demonstrated interesting results in patient outcomes [1]. Nevertheless, we would like to contribute some observations that could lead to a better understanding of this article, especially regarding its main conclusion. The authors concluded and recommended that using an IPCD and TXA and discontinuing enoxaparin and preoperative autologous blood donation eliminated blood transfusion in hip or knee arthroplasty without any increase in venous thromboembolic disease [1]. However, this could bemisleading due to thelimitations of this study.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.relation.ispartofJournal of Arthroplasty,ISSN: 0883-5403 ; EISSN: 1532-8406, Vol.31 (2016); pp.2653-2654
dc.relation.urihttps://www.arthroplastyjournal.org/action/showPdf?pii=S0883-5403%2816%2930335-7
dc.sourceJournal of Arthroplasty
dc.titleLetter to the Editor on Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid
dc.typeother
dc.publisherChurchill Livingstone Inc.
dc.publisherElsevier
dc.title.alternativeLetter to the Editor on “Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid”
dc.subject.keywordEnoxaparin
dc.subject.keywordTranexamic acid
dc.subject.keywordAnticoagulant agent
dc.subject.keywordTranexamic acid
dc.subject.keywordBleeding
dc.subject.keywordBlood donor
dc.subject.keywordBlood transfusion
dc.subject.keywordChemoprophylaxis
dc.subject.keywordDrug efficacy
dc.subject.keywordGold standard
dc.subject.keywordHuman
dc.subject.keywordIntermittent pneumatic compression device
dc.subject.keywordLetter
dc.subject.keywordPractice guideline
dc.subject.keywordPreoperative period
dc.subject.keywordThrombosis prevention
dc.subject.keywordTotal hip prosthesis
dc.subject.keywordTotal knee arthroplasty
dc.subject.keywordVenous thromboembolism
dc.subject.keywordArthroplasty
dc.subject.keywordBleeding
dc.subject.keywordKnee replacement
dc.subject.keywordVenous thromboembolism
dc.subject.keywordAnticoagulants
dc.subject.keywordArthroplasty
dc.subject.keywordArthroplasty
dc.subject.keywordreplacement
dc.subject.keywordknee
dc.subject.keywordEnoxaparin
dc.subject.keywordHemorrhage
dc.subject.keywordHumans
dc.subject.keywordTranexamic acid
dc.subject.keywordVenous thromboembolism
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.type.spaOtro
dc.rights.accesoAbierto (Texto Completo)
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doihttps://doi.org/10.1016/j.arth.2016.06.041
dc.relation.citationEndPage2654
dc.relation.citationStartPage2653
dc.relation.citationTitleJournal of Arthroplasty
dc.relation.citationVolumeVol. 31


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record